Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03308097 · ClinicalTrials.gov registry record · NA
A Mobile Intervention to Improve Uptake of PrEP for Southern Black MSM
A NA study, sponsored by Rhode Island Hospital.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT03308097 is a NA study that has completed, run by Rhode Island Hospital. The registered enrollment target is 70 participants.
The verdict
NCT03308097, a NA study, has completed, sponsored by Rhode Island Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
This study will develop and test an interactive mobile messaging intervention to improve engagement in care related to Pre-exposure Prophylaxis (PrEP) and decrease HIV risk behaviors for Black men who have sex with men living in the Southern U.S. The mobile messaging intervention will include interactive text messaging and free, publicly available links to websites and YouTube videos. During the intervention participants will gain information about their health, improve motivation for engagement in PrEP related care, and build skills for healthy behaviors. Participants will also receive intervention materials to help decrease frequent barriers to care. If the intervention is found to be effective, it can be tested in a larger study and then disseminated.
Interventions
- BEHAVIORAL Enhanced Standard of Care
- BEHAVIORAL PrEP Mobile Messaging Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2018-11-20 |
| Est. Completion | 2020-08-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03308097
The ClinicalTrials.gov registry entry for NCT03308097 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rhode Island Hospital, which has 130 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Enhanced Standard of Care is the first listed.
NCT03308097 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03308097 about?
NCT03308097 is a clinical study titled "A Mobile Intervention to Improve Uptake of PrEP for Southern Black MSM". This study will develop and test an interactive mobile messaging intervention to improve engagement in care related to Pre-exposure Prophylaxis (PrEP) and decrease HIV risk behaviors for Black men who have sex with men living in the Southern U.S. The mobile messaging intervention will include intera...
What is the current status of trial NCT03308097?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2018-11-20. Estimated completion is 2020-08-12.
What interventions are being tested in trial NCT03308097?
The interventions under investigation include: Enhanced Standard of Care (BEHAVIORAL), PrEP Mobile Messaging Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03308097?
This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.